Prediction Model for Multiple Pulmonary Nodules
1 other identifier
observational
59
1 country
1
Brief Summary
This study compares the sensitivity, specificity and accuracy of radiologists, thoracic surgeons and a predictive model (PKUM model) to discriminate malignancy from benign nodules in patients with multiple pulmonary nodules.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 1, 2019
CompletedStudy Start
First participant enrolled
January 1, 2019
CompletedFirst Posted
Study publicly available on registry
January 7, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2019
CompletedAugust 28, 2019
August 1, 2019
3 months
January 1, 2019
August 26, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Performance of PKUM model
Area under receiver operating characteristic curve (AUC) of PKUM model in predicting the probability of a nodule to be malignant in patients with multiple pulmonary nodules.
3 months
Secondary Outcomes (2)
Comparison between PKUM model and clinicians
3 months
Performance of PKUM model in equivocal nodules which is difficult to judge by clinicians
3 months
Eligibility Criteria
The population include patients with multiple pulmonary nodules who will be diagnosed and treated between January 1,2019 and March 30, 2019. Patients with at least 2 nodules resected will be enrolled in this study.
You may qualify if:
- Patients with newly discovered, 4-30 mm multiple pulmonary nodules shown on thoracic CT scans
- Patients with at least two nodules resected for pathological evaluation
You may not qualify if:
- History of malignancy within 5 years
- Presence of pneumonia or pleural effusion on thoracic CT scans
- Patients with none or only one nodule resected
- Patients with initial chemo-radiation therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking University People's Hospital
Beijing, 100044, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jun Wang
Peking University People's Hospital
- STUDY DIRECTOR
Yuqing Huang
Haidian Section of Peking University Third Hospital
- STUDY DIRECTOR
Jiabao Liu
People's Hospital Affiliated to Hebei Medical University
- STUDY DIRECTOR
Yingtai Chen
Beijing Aerospace 711 Hospital
- STUDY DIRECTOR
Mingru Li
Beijing Aerospace 731 Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief,Thoracic Surgery Service
Study Record Dates
First Submitted
January 1, 2019
First Posted
January 7, 2019
Study Start
January 1, 2019
Primary Completion
March 30, 2019
Study Completion
March 30, 2019
Last Updated
August 28, 2019
Record last verified: 2019-08